← Back to Portfolio

Lombard Medical

Lombard Medical is developing solutions for the $1.1 billion dollar abdominal aortic aneurysm (AAA) repair market. AAAs are balloon-like enlargements of the aorta which, if left untreated, may rupture and cause death. The company’s lead product, an endovascular stent graft that has been specifically designed to solve the problems that exist in treating complex tortuous anatomy, is approved in the US, Europe and Japan. Lombard is a VIPE (Venture Investment in Public Equity).

Location Didcot, UK
CEO Kurt Lemvigh
Partner Tim Haines
Website www.lombardmedical.com